These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3040509)

  • 1. Natural killer activity in patients with chronic hepatitis treated with OK432, interferon, adenine arabinoside and glycyrrhizin.
    Wada T; Arima T; Nagashima H
    Gastroenterol Jpn; 1987 Jun; 22(3):312-21. PubMed ID: 3040509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells.
    Hirofuji H; Kakumu S; Fuji A; Ohtani Y; Murase K; Tahara H
    Clin Exp Immunol; 1987 May; 68(2):348-56. PubMed ID: 2820634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro interferon producing activity of peripheral mononuclear cells in patients with chronic liver disease.
    Matsushita K; Arima T; Nagashima H
    Gastroenterol Jpn; 1987 Apr; 22(2):166-73. PubMed ID: 3036638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killing activities in chronic liver diseases and hepatocellular carcinoma.
    Ono K; Yamanaga Y; Yamamoto K; Koga SI; Nishimura J; Nawata H
    J Clin Immunol; 1996 Jan; 16(1):41-5. PubMed ID: 8926284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer (NK) cell activity and its in vitro response to interferon-alpha(Le) in chronic liver diseases and hepatocellular carcinoma.
    Hirai N; Kato Y; Kobayashi K; Hattori N
    Liver; 1986 Aug; 6(4):212-20. PubMed ID: 3022099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic active hepatitis B. Interferon-activated natural killer-like cells against a hepatoma cell line transfected with the hepatitis B virus nucleic acid.
    Actis GC; Ponzetto A; D'Urso N; Saracco G; Crepaldi T; Bellone G; Catucci LM; Zarcone D; Verme G
    Liver; 1991 Apr; 11(2):106-13. PubMed ID: 1646927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of adenine-arabinosine with glycyrrhizin in treating chronic active hepatitis].
    Zhang ZH; Yang ZH
    Zhong Xi Yi Jie He Za Zhi; 1988 Mar; 8(3):150-1, 157, 132-3. PubMed ID: 3416396
    [No Abstract]   [Full Text] [Related]  

  • 8. Intrapleural administration of OK432 in cancer patients: activation of NK cells and reduction of suppressor cells.
    Uchida A; Micksche M
    Int J Cancer; 1983 Jan; 31(1):1-5. PubMed ID: 6219961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role in nude mice of interferon and natural killer cells in inhibiting the tumorigenicity of human hepatocellular carcinoma cells infected with hepatitis B virus.
    Shouval D; Rager-Zisman B; Quan P; Shafritz DA; Bloom BR; Reid LM
    J Clin Invest; 1983 Aug; 72(2):707-17. PubMed ID: 6192149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-21 reinvigorates exhausted natural killer cells in patients with HBV-associated hepatocellular carcinoma in STAT1-depedent pathway.
    Jin Y; Sun Z; Geng J; Yang L; Song Z; Song H; Wang J; Tang J
    Int Immunopharmacol; 2019 May; 70():1-8. PubMed ID: 30780004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a streptococcal preparation (OK432) on natural killer activity of tumour-associated lymphoid cells in human ovarian carcinoma and on lysis of fresh ovarian tumour cells.
    Colotta F; Rambaldi A; Colombo N; Tabacchi L; Introna M; Mantovani A
    Br J Cancer; 1983 Oct; 48(4):515-25. PubMed ID: 6626452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [NK activity in various liver diseases--especially the relation between NK activity and reserve function of the liver in liver cirrhosis and hepatocellular carcinoma].
    Takagi H; Sakurai S; Uehara M; Yamada S; Kobayashi S
    Nihon Gan Chiryo Gakkai Shi; 1989 Oct; 24(10):2369-74. PubMed ID: 2559127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological changes in different patient populations with chronic hepatitis C virus infection.
    Szereday L; Meggyes M; Halasz M; Szekeres-Bartho J; Par A; Par G
    World J Gastroenterol; 2016 May; 22(20):4848-59. PubMed ID: 27239111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy of glycyrrhizin withdrawal and human fibroblast interferon for chronic hepatitis B.
    Hayashi J; Kashiwagi S; Noguchi A; Ikematsu H; Tsuda H; Tsuji Y; Motomura M
    Clin Ther; 1989; 11(1):161-9. PubMed ID: 2497983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycyrrhizin withdrawal followed by human lymphoblastoid interferon in the treatment of chronic hepatitis B.
    Hayashi J; Kajiyama W; Noguchi A; Nakashima K; Hirata M; Hayashi S; Kashiwagi S
    Gastroenterol Jpn; 1991 Dec; 26(6):742-6. PubMed ID: 1765247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased natural killer activity in patients with liver cirrhosis.
    Nakamura T; Morizane T; Watanabe T; Tsuchimoto K; Inagaki Y; Kumagai N; Tsuchiya M
    Int J Cancer; 1983 Nov; 32(5):573-5. PubMed ID: 6315603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between natural killer activity and development of hepatocellular carcinoma in patients with cirrhosis of the liver.
    Nakajima T; Mizushima N; Kanai K
    Jpn J Clin Oncol; 1987 Dec; 17(4):327-32. PubMed ID: 2826847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of adenine arabinoside and alpha-interferon in patients with HBeAg-positive chronic active hepatitis.
    Lee SU; Choi KH; Ha BJ; Suh SY; Han BH; Ku JY; Park BC
    Korean J Intern Med; 1990 Jan; 5(1):1-4. PubMed ID: 2271507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatocarcinoma and killer cell activity].
    Lucea D; Vargas V; Español T; Castells L; Sauleda S; Esteban R; Guardia J
    Med Clin (Barc); 1995 Sep; 105(10):370-3. PubMed ID: 7475439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Functional activity of natural killer cells in patients with chronic liver diseases].
    Dzhalalova VA; Madzhidov AV; Drozd TN; Pogromov AP
    Ter Arkh; 1985; 57(2):74-7. PubMed ID: 4002143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.